These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 30200625)
41. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells. Dhawan S; Kerru N; Awolade P; Singh-Pillay A; Saha ST; Kaur M; Jonnalagadda SB; Singh P Bioorg Med Chem; 2018 Nov; 26(21):5612-5623. PubMed ID: 30360952 [TBL] [Abstract][Full Text] [Related]
42. Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells. Bozdag M; Ferraroni M; Ward C; Carta F; Bua S; Angeli A; Langdon SP; Kunkler IH; Al-Tamimi AS; Supuran CT Eur J Med Chem; 2019 Nov; 182():111600. PubMed ID: 31419777 [TBL] [Abstract][Full Text] [Related]
43. Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged β-Lactam Triazole Hybrid. Dhawan S; Awolade P; Kisten P; Cele N; Pillay AS; Saha S; Kaur M; Jonnalagadda SB; Singh P Chem Biodivers; 2020 Jan; 17(1):e1900462. PubMed ID: 31788939 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety. Ghorab MM; Ragab FA; Hamed MM Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents. Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398 [TBL] [Abstract][Full Text] [Related]
47. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells. Li Y; Tang Q; Xie Y; He D; Yang K; Zheng L Bioorg Med Chem Lett; 2021 Feb; 33():127750. PubMed ID: 33340662 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety. Ayati A; Oghabi Bakhshaiesh T; Moghimi S; Esmaeili R; Majidzadeh-A K; Safavi M; Firoozpour L; Emami S; Foroumadi A Eur J Med Chem; 2018 Jul; 155():483-491. PubMed ID: 29908441 [TBL] [Abstract][Full Text] [Related]
49. Synthesis of pro-apoptotic indapamide derivatives as anticancer agents. Yılmaz Ö; Özbaş Turan S; Akbuğa J; Tiber PM; Orun O; Supuran CT; Küçükgüzel ŞG J Enzyme Inhib Med Chem; 2015 Dec; 30(6):967-80. PubMed ID: 25683085 [TBL] [Abstract][Full Text] [Related]
50. Design, Synthesis, and Biological Evaluation of Coumarin-Triazole Hybrid Molecules as Potential Antitumor and Pancreatic Lipase Agents. Kahveci B; Yılmaz F; Menteşe E; Ülker S Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28543820 [TBL] [Abstract][Full Text] [Related]
51. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024. Carradori S Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899 [TBL] [Abstract][Full Text] [Related]
52. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity. Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177 [TBL] [Abstract][Full Text] [Related]
53. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII. Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980 [TBL] [Abstract][Full Text] [Related]
54. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. Nocentini A; Carta F; Ceruso M; Bartolucci G; Supuran CT Bioorg Med Chem; 2015 Nov; 23(21):6955-66. PubMed ID: 26432607 [TBL] [Abstract][Full Text] [Related]
55. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII. Chandak N; Ceruso M; Supuran CT; Sharma PK Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360 [TBL] [Abstract][Full Text] [Related]
56. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity. Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071 [TBL] [Abstract][Full Text] [Related]
58. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents. Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545 [TBL] [Abstract][Full Text] [Related]
59. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567 [TBL] [Abstract][Full Text] [Related]
60. Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies. Karataş MO; Uslu H; Sarı S; Alagöz MA; Karakurt A; Alıcı B; Bilen C; Yavuz E; Gencer N; Arslan O J Enzyme Inhib Med Chem; 2016 Oct; 31(5):760-72. PubMed ID: 26207513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]